Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson's disease individuals.
- DOI
- 10.1016/j.prdoa.2025.100359
- Published
- 2025
- Container
- Clinical parkinsonism & related disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.prdoa.2025.100359,
title = {Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson's disease individuals.},
author = {Han YR and Jeong A and Ayub K and Gupta SV and Bergmann L and Kern DS and Pagan F and Rosebraugh M},
year = {2025},
journal = {Clinical parkinsonism \& related disorders},
doi = {10.1016/j.prdoa.2025.100359},
url = {https://doi.org/10.1016/j.prdoa.2025.100359}
}RIS
TY - JOUR TI - Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson's disease individuals. AU - Han YR AU - Jeong A AU - Ayub K AU - Gupta SV AU - Bergmann L AU - Kern DS AU - Pagan F AU - Rosebraugh M PY - 2025 JO - Clinical parkinsonism & related disorders DO - 10.1016/j.prdoa.2025.100359 UR - https://doi.org/10.1016/j.prdoa.2025.100359 ER -
APA
YR, H., A, J., K, A., SV, G., L, B., DS, K., F, P., & M, R. (2025). Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson's disease individuals.. Clinical parkinsonism & related disorders. https://doi.org/10.1016/j.prdoa.2025.100359
Source records
- pubmed · retrieved 2026-09-25T13:02:38.348Z